Artículos de revistas
Autologous Platelet Gel: Five Cases Illustrating Use On Sickle Cell Disease Ulcers
Registro en:
International Journal Of Lower Extremity Wounds. Sage Publications Inc., v. 13, n. 2, p. 120 - 126, 2014.
15347346
10.1177/1534734614534979
2-s2.0-84902774994
Autor
Gilli S.C.O.
Do Valle Oliveira S.A.
Saad S.T.O.
Institución
Resumen
Leg ulcers represent a particularly disabling complication in patients with sickle cell disease (SCD). Platelet gel (PG) is a novel therapeutic strategy used for accelerating wound healing of a wide range of tissues through the continuous release of platelet growth factors. Here, we describe the use of PG preparation according to Anitua's PRGF (preparations rich in growth factors) protocol for treating chronic nonhealing ulcers in patients with SCD. A positive response occurred in 3 patients with an area reduction of 85.7% to 100%, which occurred within 7 to 10 weeks, and a 35.2% and 20.5% of area reduction in 2 other patients, who however, had large ulcers. After calcium chloride addition, the platelet-rich plasmas demonstrated enhanced platelet-derived growth factors-BB (P <.001), transforming growth factor-β1 (P =.015), vascular endothelial growth factors (P =.03), and hepatocyte growth factors (nonsignificant) secretion. Furthermore, calcium chloride addition induced a significant decrease in platelet number (P =.0134) and there was no leukocyte detection in the PG product. These results demonstrate that PG treatment might impact the healing of leg ulcers in sickle cell disease, especially in patients with small ulcers. © 2014 The Author(s). 13 2 120 126 Mack, A.K., Kato, G.J., Sickle cell disease and nitric oxide: A paradigm shift? (2006) Int J Biochem Cell Biol, 38, pp. 1237-1243 Mohan, J.S., Marshall, J.M., Reid, H.L., Thomas, P.W., Serjeant, G.R., Postural vasoconstriction and leg ulceration in homozygous sickle cell disease (1997) Clin Sci (Lond), 92, pp. 153-158 Minniti, C.P., Delaney, K.M., Gorbach, A.M., Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia (2014) Am J Hematol, 89, pp. 1-6 McAleer, J.P., Sharma, S., Kaplan, E.M., Persich, G., Use of autologous platelet concentrate in a nonhealing lower extremity wound (2006) Adv Skin Wound Care, 19, pp. 354-363 Salemi, S., Rinaldi, C., Manna, F., Guarneri, G.F., Parodi, P.C., Reconstruction of lower leg skin ulcer with autologous adipose tissue and platelet-rich plasma (2008) J Plast Reconstr Aesthet Surg, 61, pp. 1565-1567 Margolis, D.J., Kantor, J., Santanna, J., Strom, B.L., Berlin, J.A., Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers (2001) Diabetes Care, 24, pp. 483-488 Marx, R.E., Platelet-rich plasma (PRP): What is PRP and what is not PRP? (2001) Implant Dent, 10, pp. 225-228 Mehta, S., Watson, J.T., Platelet rich concentrate: Basic science and current clinical applications (2008) J Orthop Trauma, 22, pp. 432-438 Anitua, E., Andia, I., Ardanza, B., Nurden, P., Nurden, A.T., Autologous platelets as a source of proteins for healing and tissue regeneration (2004) Thromb Haemost, 91, pp. 4-15 Bennett, N.T., Schultz, G.S., Growth factors and wound healing: Biochemical properties of growth factors and their receptors (1993) Am J Surg, 165, pp. 728-737 Bennett, N.T., Schultz, G.S., Growth factors and wound healing: Part II. Role in normal and chronic wound healing (1993) Am J Surg, 166, pp. 74-81 Fu, X., Li, X., Cheng, B., Chen, W., Sheng, Z., Engineered growth factors and cutaneous wound healing: Success and possible questions in the past 10 years (2005) Wound Repair Regen, 13, pp. 122-130 Goldman, R., Growth factors and chronic wound healing: Past, present, and future (2004) Adv Skin Wound Care, 17, pp. 24-35 Knighton, D.R., Doucette, M., Fiegel, V.D., Ciresi, K., Butler, E., Austin, L., The use of platelet derived wound healing formula in human clinical trials (1988) Prog Clin Biol Res, 266, pp. 319-329 Krupski, W.C., Reilly, L.M., Perez, S., Moss, K.M., Crombleholme, P.A., Rapp, J.H., A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: A preliminary report (1991) J Vasc Surg, 14, pp. 526-532 Napolitano, M., Matera, S., Bossio, M., Autologous platelet gel for tissue regeneration in degenerative disorders of the knee (2012) Blood Transfus, 10, pp. 72-77 Ganio, C., Tenewitz, F.E., Wilson, R.C., Moyles, B.G., The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors (1993) J Foot Ankle Surg, 32, pp. 263-268 Crovetti, G., Martinelli, G., Issi, M., Platelet gel for healing cutaneous chronic wounds (2004) Transfus Apher Sci, 30, pp. 145-151 Saldalamacchia, G., Lapice, E., Cuomo, V., A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers (2004) Nutr Metab Cardiovasc Dis, 14, pp. 395-396 Chen, T.M., Tsai, J.C., Burnouf, T., A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extremity ulcers (2010) Dermatol Surg, 36, pp. 453-460 Greppi, N., Mazzucco, L., Galetti, G., Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients (2011) Biologicals, 39, pp. 73-80 Anitua, E., Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants (1999) Int J Oral Maxillofac Implants, 14, pp. 529-535 Anitua, E., Aguirre, J.J., Algorta, J., Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers (2008) J Biomed Mater Res B Appl Biomater, 84, pp. 415-421 Carter, M.J., Fylling, C.P., Parnell, L.K., Use of platelet rich plasma gel on wound healing: A systematic review and meta-analysis (2011) Eplasty, 11, p. 38 Balfour, J.A., Noble, S., Becaplermin (1999) BioDrugs, 11, pp. 359-364 Cruciani, M., Lipsky, B.A., Mengoli, C., De Lalla, F., Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections (2009) Cochrane Database Syst Rev, 3, pp. CD006810 Cruciani, M., Lipsky, B.A., Mengoli, C., De Lalla, F., Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections? A meta-analysis (2005) Diabetes Care, 28, pp. 454-460 Dougherty, E.J., An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers (2008) Adv Skin Wound Care, 21, pp. 568-575 Hebbel, R.P., Osarogiagbon, R., Kaul, D., The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy (2004) Microcirculation, 11, pp. 129-151 Belcher, J.D., Marker, P.H., Weber, J.P., Hebbel, R.P., Vercellotti, G.M., Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion (2000) Blood, 96, pp. 2451-2459 Patel, N., Gonsalves, C.S., Malik, P., Kalra, V.K., Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha (2008) Blood, 112, pp. 856-865 Kato, G.J., Martyr, S., Blackwelder, W.C., Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality (2005) Br J Haematol, 130, pp. 943-953 Duits, A.J., Rojer, R.A., Van Endt, T., Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease (2003) Ann Hematol, 82, pp. 171-174 Brittain, J.E., Parise, L.V., Cytokines and plasma factors in sickle cell disease (2007) Curr Opin Hematol, 14, pp. 438-443 Tomer, A., Harker, L.A., Kasey, S., Eckman, J.R., Thrombogenesis in sickle cell disease (2001) J Lab Clin Med, 137, pp. 398-407 Browne, P.V., Mosher, D.F., Steinberg, M.H., Hebbel, R.P., Disturbance of plasma and platelet thrombospondin levels in sickle cell disease (1996) Am J Hematol, 51, pp. 296-301 Raines, E.W., Ross, R., Platelet-derived growth factor. I. High yield purification and evidence for multiple forms (1982) J Biol Chem, 257, pp. 5154-5160 Oates, T.W., Rouse, C.A., Cochran, D.L., Mitogenic effects of growth factors on human periodontal ligament cells in vitro (1993) J Periodontol, 64, pp. 142-148 Matsuda, N., Lin, W.L., Kumar, N.M., Cho, M.I., Genco, R.J., Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro (1992) J Periodontol, 63, pp. 515-525 Wrana, J.L., Maeno, M., Hawrylyshyn, B., Yao, K.L., Domenicucci, C., Sodek, J., Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations (1988) J Cell Biol, 106, pp. 915-924 Bowers, A.S., Reid, H.L., Greenidge, A., Landis, C., Reid, M., Blood viscosity and the expression of inflammatory and adhesion markers in homozygous sickle cell disease subjects with chronic leg ulcers (2013) PLoS One, 8 (7), pp. e68929 Yager, D.R., Zhang, L.Y., Liang, H.X., Diegelmann, R.F., Cohen, I.K., Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids (1996) J Invest Dermatol, 107, pp. 743-748